The BioTrinity programme takes place over three days from May 12th to May 14th and will include company showcase presentations from Europe's best biotech and medtech companies, investor and pharma panel discussions.
If you wish us to consider including your company in the list of showcase presentations in 2014, contact Jon Rees for more information.
The BioTrinity 2013 programme was heralded as a great success and included 86 hand-picked company showcase presentations from Europe's best biotech and medtech companies; nine key opinion leader investor and pharma panel discussions covering the choices for financing and exits for life sciences companies, whether that be corporate venture/VC/equity financing, licensing deals or pharma acquisition, discusses notables success stories and how they were achieved; and also interactive workshops to update you on the latest industry trends and advice, including a new "What Pharma Wants?" workshop series in which pharma licensing execs tell you exactly what they are looking for. BioTrinity 2013 also hosted the UK presentation of Ernst & Young’s Beyond Borders Global Biotechnology Report 2013.
More detail about the 2013 agenda:
Once again for 2014, partnering will be available on the Monday evening (May 12) during the Welcome Reception. Details of the many networking opportunities can be found in the social programme.